Logo 5029 5/120 (Cetirizine and pseudoephedrine extended release 5 mg / 120 mg)
Pill imprint Logo 5029 5/120 has been identified as Cetirizine and pseudoephedrine extended release 5 mg / 120 mg.
Cetirizine/pseudoephedrine is used in the treatment of allergic rhinitis and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Cetirizine/pseudoephedrine 5 mg / 120 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 5 mg / 120 mg
- Yellow & White
- Rx and/or OTC
More about cetirizine/pseudoephedrine
- Cetirizine and pseudoephedrine
- Cetirizine and pseudoephedrine (Advanced Reading)
- Cetirizine and Pseudoephedrine (FDA)
- Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride (Wolters Kluwer)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.